Profile picture

Doctor Francesco Santoro

University of Foggia - Faculty of Medecine, Foggia (Italy)
Membership: EHRA Member
Follow
Biography
Francesco Santoro, MD, PhD, is a consultant in cardiology at the University hospital of Foggia, Policlinico Riuniti, Italy. In 2013, he attended for six months Texas Arrhythmia Institute, Austin, Texas, USA under the supervision of Dr. Andrea Natale. Between 2015 and 2018 he attended the electrophysiology laboratory at the Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany. Research topic: Cardiomyopathies (Takotsubo syndrome) and catheter ablation of Atrial Fibrillation and Ventricular Tachycardia (Papillary muscles VT/VF). He authored 180 publications in indexed journals, about 175 abstracts and 6 electrophysiology book chapters.
Logo ESC

Contributor content

Cardiac Calsequestrin (CASQ2) as potential cause of Brugada Syndrome: investigation of a large italian family
Presentation
Cardiac Calsequestrin (CASQ2) as potential cause of Brugada Syndrome: investigation of a large italian family
Oral flecainide therapy and myocardial pacing: preliminary data from a prospective multicenter registry
Presentation
Oral flecainide therapy and myocardial pacing: preliminary data from a prospective multicenter registry
Immune modulating drugs and oral anticoagulation in kidney transplant recipients: comparison of direct oral anticoagulants versus antagonist of vitamin-k. results from a multicenter prospective study.
Presentation
Immune modulating drugs and oral anticoagulation in kidney transplant recipients: comparison of direct oral anticoagulants versus antagonist of vitamin-k. results from a multicenter prospective study.
Long-term mayor adverse cardiovascular events after covid-19 infection: a clinical score from a cohort of 2575 patients enrolled in the multicenter international HOPE 2 registry
Presentation
Long-term mayor adverse cardiovascular events after covid-19 infection: a clinical score from a cohort of 2575 patients enrolled in the multicenter international HOPE 2 registry
Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: A propensity score-matched cohort analysis of the HOPE-COVID-19 registry.
Presentation
Aspirin therapy on prophylactic anticoagulation for hospitalized patients with COVID-19: A propensity score-matched cohort analysis of the HOPE-COVID-19 registry.
Fever following Covid-19 vaccination in subjects with Brugada syndrome: incidence and management.
Presentation
Fever following Covid-19 vaccination in subjects with Brugada syndrome: incidence and management.
Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).
Presentation
Antiplatelet therapy and outcome in patients with COVID-19. Results from a multi-center international prospective registry (HOPE-COVID19).
Neoplastic markers in Takotsubo syndrome. Results from a prospective registry.
Presentation
Neoplastic markers in Takotsubo syndrome. Results from a prospective registry.
Prevalence, management and outcome of life-threatening arrhythmias in  Takotsubo Syndrome:
Presentation
Prevalence, management and outcome of life-threatening arrhythmias in Takotsubo Syndrome:
Takotsubo syndrome in patients with malignancies: a metanalysis.
Presentation
Takotsubo syndrome in patients with malignancies: a metanalysis.

ESC 365 is supported by